| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 10.94B | 10.91B | 9.55B | 7.77B | 6.38B | 5.70B |
| Gross Profit | 6.74B | 6.56B | 5.86B | 4.63B | 3.93B | 3.33B |
| EBITDA | 5.50B | 5.54B | 4.40B | 3.58B | 2.93B | 2.53B |
| Net Income | 2.84B | 2.86B | 1.91B | 1.69B | 1.28B | 1.02B |
Balance Sheet | ||||||
| Total Assets | 33.00B | 28.49B | 27.06B | 21.67B | 20.04B | 14.22B |
| Cash, Cash Equivalents and Short-Term Investments | 6.61B | 8.12B | 8.79B | 6.54B | 5.89B | 4.29B |
| Total Debt | 9.10B | 9.32B | 10.46B | 8.03B | 7.70B | 6.70B |
| Total Liabilities | 17.23B | 13.04B | 14.27B | 10.69B | 10.50B | 8.70B |
| Stockholders Equity | 15.77B | 15.45B | 12.79B | 10.98B | 9.54B | 5.52B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 782.75M | 776.70M | 851.89M | -1.12B | -299.48M |
| Operating Cash Flow | 0.00 | 4.17B | 2.65B | 2.85B | 1.81B | 1.77B |
| Investing Cash Flow | 0.00 | -3.47B | -2.85B | -2.24B | -3.91B | -2.06B |
| Financing Cash Flow | 0.00 | -1.38B | 2.26B | 39.93M | 3.70B | 827.70M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥82.14B | 5.37 | ― | 2.77% | 24.61% | 185.90% | |
73 Outperform | ¥185.28B | 17.31 | 11.00% | 2.20% | 6.63% | -3.05% | |
73 Outperform | ¥27.81B | 7.02 | ― | 2.62% | -9.37% | 590.66% | |
73 Outperform | ¥392.58B | 25.33 | ― | 1.30% | 8.33% | 1.73% | |
69 Neutral | ¥52.35B | 16.18 | ― | 0.73% | 6.25% | 23.69% | |
66 Neutral | ¥7.74B | 16.59 | ― | 1.36% | 3.68% | -24.83% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |